O-arm

Iqbal, Subhan

doi:10.53347/rid-98149

Cited by 3 publications

(6 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While most social media platforms are dominated by content targeted purely at the viewers’ entertainment, both viewers and platform developers are fueling a growing demand for content with educational value . This contentedutainmentis a form of entertainment intended to educate, amuse, instruct and/or socialize an audience by embedding lessons in media. , Previous studies have shown that edutainment can increase confidence, engagement, critical thinking, and growth mindsets. , Edutainment has long permeated television and online games (e.g., “Sesame Street” and “Leapfrog”) but has recently begun to infiltrate social media.…”

Section: Combining Education and Entertainment: Edutainmentmentioning

confidence: 99%

“…As science education continues to rise in popularity, short-form video platforms have become an exciting new medium through which science communicators can engage with the public. While discussions of social media edutainment have begun to appear in the literature, ,, our goal is to provide some fundamental guidelines for designing engaging and scientific social media channels through short-form video platforms.…”

Section: Combining Education and Entertainment: Edutainmentmentioning

confidence: 99%

See 1 more Smart Citation

Short-Form Videos as an Emerging Social Media Tool for STEM Edutainment

Prindle,

Orchanian,

Venkataraman

et al. 2024

J. Chem. Educ.

View full text Add to dashboard Cite

As social media platforms continue to grow in popularity, there is an increasing need for science outreach teams to bring STEM content to the virtual landscape. Here, we highlight the use of shortform videos on our TikTok channel�@IvyLeagueScience�as a new way to approach science outreach. Through a combination of content production and data analytics, we were able to build an online platform with >150k followers, 3.6 million likes, and 18 million views. By bringing science to social media, we engage with students across the world, allowing them to experience science-based content. In this case study, we hope to encourage other scientific outreach teams to employ social media as a means of increasing visibility of scientists and STEM careers.

show abstract

Section: Combining Education and Entertainment: Edutainmentmentioning

confidence: 99%

Section: Combining Education and Entertainment: Edutainmentmentioning

confidence: 99%

Short-Form Videos as an Emerging Social Media Tool for STEM Edutainment

Prindle,

Orchanian,

Venkataraman

et al. 2024

J. Chem. Educ.

View full text Add to dashboard Cite

show abstract

“…These medications have a rapid onset of action, with a plasma half-life of approximately two hours for tirofiban [ 35 ]. However, they are only available intravenously and are used as short-term therapy [ 4 ].…”

Section: Reviewmentioning

confidence: 99%

“…Cilostazol is a medication commonly used in antiplatelet therapy after PCI in patients with ACS. The long-term effect of cilostazol therapy has yet to be completely discovered, but several studies have reported the potential benefits and side effects [ 4 ]. Cilostazol is a phosphodiesterase III inhibitor and an antiplatelet agent.…”

Section: Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy, Safety, and Role of Antiplatelet Drugs in the Management of Acute Coronary Syndrome: A Comprehensive Review of Literature

Abubakar¹,

Raza²,

Hassan³

et al. 2023

Cureus

View full text Add to dashboard Cite

Acute coronary syndrome (ACS) is a complex condition characterized by myocardial ischemia or infarction which can lead to significant morbidity and death. Antiplatelet drugs play a crucial role in the management of ACS and have been shown to minimize the incidence of significant adverse cardiovascular events and recurrent myocardial infarction (MI). This comprehensive literature review is intended to summarize current information on the effectiveness, safety, and function of frequently used antiplatelet medications in treating ACS.Aspirin, clopidogrel, prasugrel, ticagrelor, abciximab, tirofiban, dipyridamole, cilostazol, and novel antiplatelets are included in the review. Aspirin's effectiveness as a first-line antiplatelet medication in ACS is well established. It has significantly lowered the risk of serious adverse cardiovascular events. Clopidogrel, prasugrel, and ticagrelor are P2Y12 receptor inhibitors found to lower the incidence of recurrent ischemia episodes in ACS patients.Using glycoprotein IIb/IIIa inhibitors such as abciximab, tirofiban, and eptifibatide is effective in managing ACS, especially in high-risk patients. Dipyridamole effectively reduces the risk of recurrent ischemic events in patients with ACS, particularly when used with aspirin. Cilostazol, a phosphodiesterase III inhibitor, has also been shown to reduce the risk of major adverse cardiovascular events (MACE) in patients with ACS.Antiplatelet drugs' safety in managing ACS has also been well established. Aspirin is generally well-tolerated with a low risk of adverse effects, although the risk of bleeding events, particularly gastrointestinal bleeding, cannot be eliminated. The P2Y12 receptor inhibitors have been associated with a small increase in the risk of bleeding events, particularly in patients with a high risk of bleeding. The glycoprotein IIb/IIIa inhibitors are associated with a higher risk of bleeding than other antiplatelet drugs, especially in high-risk patients.To summarize, antiplatelet drugs play a crucial role in the management of ACS, and the efficacy and safety of these drugs have been well-established in the literature. The choice of antiplatelet drugs will depend on the patient's risk factors, including age, comorbidities, and bleeding risk. The novel antiplatelets may offer new therapeutic options for managing ACS, and further studies are needed to determine their role in managing this complex condition.

show abstract